Nervenheilkunde, Table of Contents Nervenheilkunde 2003; 22(11): 603-615DOI: 10.1055/s-0038-1626356 Original- und Übersichtsarbeiten/Original and Review Articles Schattauer GmbH 8. Kopfschmerz zurückzuführen auf eine Substanz oder deren Entzug Recommend Article Abstract Buy Article Full Text References Literatur 8.1 Kopfschmerz induziert durch akuten Substanzgebrauch oder akute Substanzexposition Altura B.M., Altura B.T., Gebrewold A. Alcohol induced spasm of cerebral blood vessels. J Mental Sci 2000; 104: 972-999. Armstrong P.J., Bersten A. 1986; Normeperidine toxicity. Anesth Analg 65: 536-538. Ashina M, Bendtsen L, Jensen R, Olesen J. Nitric oxide-induced headache in patients with chronic tension-type headache. Brain 2000; 123: 1830-1837. Bouillabaisse: an outbreak of methemoglobinemia in New Jersey in. 1992; Pediatrics 94: 381-384. Askmark H, Lundberg P.O., Olsson S. Drug related Headache. Headache 1989; 29: 441-444 Atkins, F.M. (1986). A critical evaluation of clinical trials in adverse reactions to foods in adults. J Allergy Clin Immunol. 78:174-182. Beck H.G., Schulze W.H., Suter G.M.. 1940; Carbon monoxide-a domestic hazard. JAMA 115: 1. Bonnet G.F., Nepveux P. 1971; Migraine due to tyramine. Sem Hop 47: 2441-2445. Brewerton T.D., Murphy D.L., Lesem M.D., Brandt H.A., Jimerson D.C.. 1992; Headache responses following m-chlorophenylpiperazine in bulimics and controls. Headache 32: 217-22. Catalano G, Catalano M.C., Rodriguez R. 1997; Dystonia associated with crack cocaine use. South Med J 90: 1050-1052. Cleophas T.J., Niemeyer M.G., vanderWall E.E., vanderMeulen J. 1996; Nitrate-induced headache in patients with stable angina pectoris: beneficial effect of starting on a low dose. Angiology 47: 679-685. Council of Affairs Scientific. 1985; Aspartame: review of safety issues. JAMA 254: 400-402. Cregler L.L., Mark H. 1986; Medical complications of cocaine abuse. N Engl J Med 315: 1495-1501. Dalton K. 1976; Migraine and oral contraceptives. Headache 15: 247-251. Dhopesh V, Maany I, Herring C. 1991; The relationship of cocaine to headache in polysubstance abusers. Headache 31: 17-19. Dhuna A, Pascual-Leone A, Belgrade M. Cocaine-related vascular headaches. J Neurol Neurosurg Psychiat 1991; 54: 803-6. De Marinis M, Janiri L, Agnoli A. Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 1991; 31: 159-163. Ekbom K. 1968; Nitroglycerin as a provocative agent in cluster headache. Arch Neurol 19: 487-493. el-Mallakh R.S.. 1987; Marijuana and migraine. Headache 27: 442-443. el-Mallakh R.S., Kranzler H.R., Kamanitz J.R.. 1991; Headaches and psychoactive substance use. Headache 31: 584-587. Forbes H.S., Cobb S, Fremont-smith F. 1924; Cerebral edema and headache following carbon monoxide asphyxia. Arch Neurol Psychiatr 11: 164. Gawin F.H.. 1991; Cocaine addiction: psychology and neurophysiology. Science 251: 1580-1586. Ghose K, Carrol J.D.. 1984; Mechanisms of tyramine-induced migraine: similarities with dopamine and interactions with disulfiram and propranolol. Neuropsychiobiol 12: 122-126. Gordon C.R., Mankuta D, Shupak A, Spitzer O, Doweck I. 1991; Recurrent classic migraine attacks following transdermal scopolamine intoxication. Headache 31: 172-174. Gore M.E., Salmon P.R.. Chinese restaurant syndrome: fact or fiction. Lancet 1980; 318: 251-2. Hanington E, Harper A.M.. 1968; The role of tyramine in the etiology of migraine and related studies on the cerebral and intracerebral circulations. Headache 08: 84-97. Hansen H.J., Drewes V.M.. 1970; The nitroglycerine ointment test-a double-blind examination. Dan Med Bull 17: 226-229. Heckerling P.S., Leikin J.B., Maturen A, Perkins J.T.. 1987; Predictors of occult carbon monoxide poisoning in patients with headache and dizziness. Ann Int Med 107: 174-176. Henderson W.R., Raskin N.H.. 1972; »Hot dog« headache: individual susceptibility to nitrite. Lancet 02: 1162-1163. Hirsch A.R., Rankin K.M., Panelli P.P.. 1996; Trichloroethylene exposure and headache. Headache Quarterly 07: 126-138. Horowitz L.D., Herman M.V., Gorlin R. 1972; Clinical response to nitroglycerine as a diagnostic test for coronary artery disease. Am J Cardiol 29: 149-153. Iversen H.K., Nielsen T.M., Olesen J, Tfelt-Hansen P. 1989; Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 38: 17-24. Kenney R.A., Tidball C.S.. 1972; Human susceptibility to oral monosodium 1-glutamate. Am J Clin Nutr 25: 140-146. Kerr G.R., Lee M.W., elLozy M, McGandy R, Stare F. 1979; Prevalence of the »Chinese restaurant syndrome«. J Am Diet Assoc 75: 29-33. Krabbe A.A., Olesen J. 1980; Headache provocation by continuous intravenous infusion of histamine, clinical results and receptor mechanisms. Pain 08: 253-259. Larkin J.M., Brahos G.J., Moylin J.A.. 1976; Treatment of carbon monoxide poisoning: prognostic factors. J Trauma 16: 111. Lassen L.H., Thomsen L.L., Olesen J. 1995; Histamine induces migraine via the H receptor. Support for the NO-hypothesis of migraine. Neuroreport 06: 1475-1479. Leon A.S., Hunninghake D.B., Bell C, Rassin D.K., Tephly T.R.. 1989; Safety of long-term doses of aspartame. Arch Int Med 149: 2318-2324. Leone M, Attanasio A, Croci D, Filippini G, D’Amico D, Grazzi L, Nespolo A, Bussone G. 2000; The serotonergic agent m-chlorophenylpiperazine induced migraine attacks: a controlled study. Neurology 55: 136-139. Levine S.R., Brust J.C., Futrell N. et al. 1990; Cerebrovascular complications of the use of the crack form of alkaloidal cocaine. N Engl J Med 323: 699-704. Lipton R.B., Kwong C.M., Solomon S. Headaches in hospitalized cocaine users. Headache 1989; 29: 225-8. Lowenstein D.H., Massa S.M., Rowbotham M.C.. et al. 1987; Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 83: 841-846. Luthy J, Schlatter C. 1983; Biogenic amines in food: effects of histamine, tyramine and phenylethylamine in the human. Z Lebensm Unters Forsch 177: 439-443. Magos A.L., Brewster E, Singh R, O’Dowd T, Brincat M, Studd J.W.W. 1986; The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 93: 1290-1296. McCullock J, Harper A.M.. 1978. Phenylethylamine and the cerebral circulation. In: Current concepts in migraine research. Mc-Cullock J, Harper A.M.. eds. 85-88 Raven Press; New York: Meigs J.L., Hughes J.P.. 1952; Acute carbon monoxide poisoning: an analysis of 105 cases. AMA Arch Ind Hygiene Occupat Med 06: 344-356. Merkel P.A., Koroshetz W.J., Irizarry M.C., Cudkovicz M.E.. 1995; Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 25: 172-183. Merrit J.E., Williams P.B.. 1990; Vasospasm contributes to monosodium glutamate-induced headache. Headache 30: 575-580. Mitchell J.D.. 1995. Clinical neurotoxicology: In: Handbook of clinical neurology. DeWolff F.A.. ed. 1-22 Elsevier Science; Moffet A.M., Swash M, Scott D.F.. 1974; Effect of chocolate in migraine: a double-blind study. J Neurol Neurosurg Psychiatry 37: 445-448. Monteiro J.M.. 1993. Headache associated with single use of substances. In: The headaches. Olesen J, Tfelt-Hansen P, Welch K.M.A. eds.) 715-720 Raven Press, Limited; New York: Monteiro J.M., Dahlof C.G.. 2000. Single use of substances. In: The Headaches. Olesen J, Tfelt-Hansen P, Welch K.M.. eds. 861-869 Lippincott Williams & Wilkins; Philadelphia: Murphree A.B., Greenberg L.A., Carrol R.B.. 1967; Neuropharmacologic effects of substances other than ethanol in alcoholic beverages. Fed Proc 26: 1468-1473. Nappi R.E., Cagnacci A, Granella F, Piccinini F, Polatti F, Facchinetti F. 2001; Course of primary headaches during hormone replacement therapy. Maturitas 38: 157-63. Norton S. 1975. Toxicology of the central nervous system. In: Toxicology. Casarett L.J., Doult J. eds. 1019-1035 MacMillan; New York: Ogata S, Hosoi T, Saji H. Studies on acute alcohol intoxication. Japanese Journal of Studies of Alcohol 1966; 01: 67-79. Peters G.A.. 1953; Migraine: diagnosis and treatment with emphasis on the migraine-tension headache, provocative tests and use of rectal suppositories. Proc Mayo Clin 28: 673-686. Reif-Lehrer L. 1977; A questionnaire study of the prevalence of Chinese restaurant syndrome. Fed Proc 36: 1617-1623. Sabatini U, Rascol O, Rascol A, Montastruc J.L.. 1990; Migraine attacks induced by subcutaneous apomorphine in two migrainous Parkinson Ian patients. Clin Neuropharmacol 13: 264-267. Satel S.L., Gawin F.H.. 1989; Migraine-like headache and cocaine use. JAMA 261: 2995-2996. Schamburg H.H., Byck R, Gerstl R, Mashman J.H.. 1969; Monosodium L-glutamate: its pharmacology and role in the Chinese restaurant syndrome. Science 163: 826-828. Scher W, Scher B.M.. 1992; A possible role for nitric oxide in glutamate (MSG)-induced Chinese restaurant syndrome, glutamate induced asthma, »hot-dog headache«, pugilistic Alzheimer’s disease, and other disorders. Med Hypotheses 38: 185-188. Schiffmann S.S., Buckley C.E., Sampson H.A.. et al. 1987; Aspartame and susceptibility to headache. N Engl J Med 317: 1181-1185. Schnitker M.T., Schnitker M.A.. 1947; Clinical notes, suggestions and new instruments. J Amer Med Assoc 135: 89. Schwartz A.M.. 1946; The cause, relief and prevention of headache arising from contact with dynamite. N Engl J Med 235: 541-544. Scopp A.L.. 1991; MSG and hydrolyzed vegetable protein induced headache review and case studies. Headache 31: 107-110. Seltzer S. 1982; Foods and drug combinations, responsible for head and neck pain. Cephalalgia 02: 111-124. Shaw S.W., Johnson R.H., Keogh H.G.. 1978. Oral tyramine in dietary migraine sufferers. In: Current concepts in migraine research. Shaw S.W., Johnson R.H., Keogh H.G.. eds31-39 Raven Press; New York: Shively M, Riegel B. 1991; Effect of nitroglycerin ointment placement on headache and flushing in health subjects. Int J Nurs Stud 28: 153-161. Sicuteri F, Bene E.D., Poggioni M, Bonazzi A. 1987; Unmasking latent dysnociception in healthy subjects. Headache 27: 180-185. Smith I, Kellow A.H., Hanington E. 1970; Clinical and biochemical correlation between tyramine and migraine headache. Headache 10: 43-52. Tarasoff L, Kelly M.F.. 1993; Monosodium Lglutamate: a double-blind study and review. Food Chem Toxicol 31: 1019-1035. Thomsen L.L., Kruse C, Iversen H.K., Olesen J. A Nitric oxide donor triggers genuine migraine attacks. Eur J Neurol 1994; 01: 71-80. Towers C.V., Pircon R.A., Nageotte M.P., Porto M, Garite T.J.. 1993; Cocaine intoxication presenting as preeclampsia and eclampsia. Ob Gyn 81: 545-547. Trelles L, Jeri R. Central nervous system stimulants: cocaine, amphetamine, nicotine. In: Handbook of clinical neurology. DeWolff F.A.. ed. New York: Elsevier Science; 1995: 251-7. Wallgreen H, Barry A. Drug actions in relation to alcohol effects. In: Action of alcohol. New York: Elsevier; 1970: 621-714. Wilson J. 1995. Cyanogenic glycosides. Ch. 3 in Handbook of clinical neurology. vol. 65 DeWolff F.A.. ed. New York: Elsevier Science; 1995 25-34. Varon J, Marik P.E., Fromm R.E., Gueler A. Carbon Monoxide Poisoning: a review for clinicians. J. Emerg Med 1999; 17: 87-93. Yang W.H., Drouin M.A., Herbert M, Mao Y, Kursh J. 1997; The monosodium glutamate symptom complex: assessment in a double blind, placebo controlled, randomized study. J Allergy Clin Immunol 99: 757-762. 8.2 Kopfschmerz bei Medikamentenübergebrauch Ala-Hurula V, Myllyla V, Hokkanen E. 1982; Ergotamine abuse: results of ergotamine discontinuation with special reference to the plasma concentrations. Cephalalgia 02: 189-195. Ala-Hurula V, Myllyla V, Hokkanen E, Tokola O. 1981; Tolfenamic acid and ergotamine abuse. Headache 21: 240-242. Allgulander C. 1986; History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatr Scand 73: 465-478. Andersson P.G.. 1975; Ergotamine headache. Headache 15: 118-121. Baar H.A.. 1990; Treatment for headache: a fourstep standardized withdrawal program for analgesic abusers. Pain Clin 03: 173-177 (Abstract). Bennett W.M., DeBroe M.E.. 1989; Analgesic nephropathy: a preventable renal disease. N Eng J Med 320: 1269-1271. Bowdler I, Killian J, Gänsslen-Blumberg S. The association between analgesic abuse and headache—coincidental or causal. Headache 1988; 28: 494. Braithwaite R.A.. The toxicity of tricyclic and newer antidepressants. In: Handbook of Clinical Neurology. DeWolff F.A.. ed. 311-320 New York: Elsevier Science; 1995: 311-20. Brust J.C.. 1995. Opiate addiction and toxicity. Ch. 16 in Handbook of clinical neurology. vol. 65 DeWolff F.A.. ed. New York: Elsevier Science; 356-361. Catarci T, Fiacco F, Argentino C. 1994; Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia 14: 374-375. Centonze V, Polite B.M., diBari M, Caporaletti P, Albano O. 1993; Vascular injuries in ergotamine abuse: a case report. Funct Neurol 08: 265-270. Dalquen P, Fasel J, Mihatsch M.J., Rist M, Rutishauser G. 1980; Phenacetinabusus IV. Sind zytologische harnuntersuchungen in der tumorvorsorge bei phenacetinabusern erfolgversprechend und anwendbar. Schweizerische Medizinische Wochenschrift 110: 302-306. DeBroe M.E., Elseviers M.M.. 1993; Analgesic nephropathy—still a problem?. Nephron 64: 505-513. deMarinis M, Janiri L, Agnoli A. 1991; Headache in the use and withdrawal of opiates and other associated substances of abuse. Headache 31: 159-163. Diamond S, Dalessio D.J.. 1982. Drug abuse in headache. In: The practicing physician’s approach to headache. Diamond S, Dalessio D.J.. eds. 114-121 Williams & Wilkins, Baltimore; Dichgans J, Diener H.C.. 1988. Clinical manifestations of excessive use of analgesic medication. In: Drug-induced headache. Diener H.C., Wilkinson M. eds. 8-15 Springer-Verlag; Berlin: Dichgans J, Diener H.D., Gerber W.D.. et al. 1984; Analgetika-induzierter dauerkopfschmerz. Dtsch Med Wschr 109: 369-73. Diener H.C.. 1993; A personal view of the classification and definition of drug dependence headache. Cephalalgia 13: 68-71. Diener H.C., Dahlof C.G.. 1999. Headache associated with chronic use of substances. In: The headaches. Olesen J, Tfelt-Hansen P, Welch K.M.A. eds. 871-878 Lippincott, Williams & Wilkins; Philadelphia: Diener H.C., Dichgans J, Scholz E, Geiselhart S, Gerber W.D., Bille A. 1989; Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236: 9-14. Diener H.C., Haab J, Peters C, Ried S, Dichgans J, Pilgrim A. 1991; Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 31: 205-209. Diener H.C., Pfaffenrath V, Soyka D, Gerber W.D.. 1992; Therapie des medikamenten-induzierten dauerkopfschmerzes. Münch Med Wschr 134: 159-162. Diener H.C., Tfelt-Hansen P. 1993. Headache associated with chronic use of substances. In: The headaches. Olesen J, Tfelt-Hansen P, Welch K.M.A. eds. 721-727 Raven press LTD; New York: Dige-Petersen H, Lassen N.A., Noer J, Toennesen K.H., Olesen J. 1977; Subclinical ergotism. Lancet i: 65-66. Drucker P, Tepper S. 1998; Daily sumatriptan for detoxification from rebound. Headache 38: 687-690. Dubach U.C., Rosner B, Pfister E. 1983; Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med 308: 357-362. Elkind A.H.. 1989; Drug abuse in headache patients. Clin J Pain 05: 111-120. Elkind A.H.. 1991; Drug abuse and headache. Med Clin N Am 75: 717-732. Evers S, Gralow I, Bauer B, Suhr B, Buchheister A, Husstedt I.W., Ringelstein E.B.. 1999; Sumatriptan and ergotamine overuse and druginduced headache: a clinicoepidemiologic study. Clin Neuropharmacol 22: 201-206. Fanciullaci M, Alessandri M, Pietrini U, Briccolani-Bandini E, Beatrice S. 1992; Longterm ergotamine abuse: effect on adrenergically induced mydriasis. Clin Pharm Ther 51: 302-307. Fincham J.E.. 1987; Over-the-counter drug use and misuse by the ambulatory elderly: a review of the literature. J Ger Drug Ther 01: 3-21. Fincham R.W., Perdue Z, Dunn V.D.. 1985; Bilateral focal cortical atrophy and chronic ergotamine abuse. Neurology 35: 720-722. Fisher C.M.. 1988; Analgesic rebound headache refuted. Headache 28: 666. Friedman A.P., Brazil P, vonStorch T.J.. 1955; Ergotamine tolerance in patients with migraine. JAMA 157: 881-884. Gaist D, Hallas J, Sindrup S.H., Gram L.F.. 1996; Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 50: 161-165. Gaist D, Tsiropoulus I, Sindrup S.H., Hallas J, Rasmussen B.K., Kragstrup J. 1998; Inappropriate use of sumatriptan: population based register and interview study. Br J Med 316: 1352-1353. Granella F, Farina S, Malferrari G, Manzoni G.C.. 1987; Drug abuse in chronic headache: a clinicoepidemiologic study. Cephalalgia 07: 15-19. Gutzwiller F, Zemp E. 1986. Der analgetikakonsum in der bevölkerung und socioökonomische aspekte des analgetikaabusus. In: Das analgetikasyndrom. Mihatsch M.J.. ed. 197-205 Thieme, Stuttgart; Hering R, Steiner T.J.. 1991; Abrupt outpatient withdrawal from medication in analgesicabusing migraineurs. Lancet 337: 1442-1443. Hokkanen E, Waltimo O, Kallanranta T. 1978; Toxic effects of ergotamine used for migraine. Headache 18: 95-98. Horowski R, Ziegler A. 1988. Possible pharmacological mechanisms of chronic abuse of analgesics and other antimigraine drugs. In: Drug-induced headache. Diener H.C., Wilkinson M. eds. 95-104 Springer-Verlag; Berlin: Horton B.T., Peters G.A.. 1963; Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 03: 214-226. Isler H. 1982. Migraine treatment as a cause of chronic migraine. In: Advances in migraine re search and therapy. Rose F.C.. ed. 159-164 Raven Press, New York: Jaffe J.H.. 1985. Drug addiction and drug abuse. In: The pharmacological basis of therapeutics. Gilman A.G., Rall T.W., Nies A.S., Taylor P. eds. 522-573 Pergamon Press; New York: Katsarava Z, Fritsche G, Muessig M, Diener H.C., Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57: 1694-1698. Kaube H, May A, Diener H.C., Pfaffenrath V. 1994; Sumatriptan misuse in daily chronic headache. Br Med J 308: 1573. Kielholz P, Ladewig D. 1981; Probleme des medikamentenmi beta-brauches. Schweiz Arztezeitung 62: 2866-2869. Klapper J.A.. 1992; Rebound headache: definition, symptomatology, treatment, and prevention. Headache Quarterly 03: 398-402. Kouyanou K, Pither C.E., Rabe-Hesketh S, Wessely S. 1998; A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically explained symptoms. Pain 76: 417-426. Kudrow L. 1982; Paradoxical effects of frequent analgesic use. Adv Neurol 33: 335-341. Lader M. Hypnotics and sedatives. In: Handbook of clinical neurology. DeWolff F.A.. ed. New York: Elsevier Science: 1995: 329-55. Lance F, Parkes C, Wilkinson M. 1988. Does analgesic abuse cause headache de novo?. Headache. 61-62. Lance J.W.. 1990; A concept of migraine and the search for the ideal headache drug. Headache 30: 17-23. Limmroth V, Kazarawa S, Fritsche G, Diener H.C.. 1999; Headache after frequent use of new 5-HT agonists zolmitriptan and naratriptan. Lancet 353: 378. Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener H.C.. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59: 1011-1014. Lucas R.N., Falkowski W. 1973; Ergotamine and methysergide abuse in patients with migraine. Br J Psychiatry 122: 199-203. Ludolph A.C., Husstedt I.W., Schlake H.P., Grotemeyer K.H., Brune G.G.. 1988; Chronic ergotamine abuse: evidence of functional impairment of long ascending spinal tracts. Eur Neurol 28: 311-316. MacGregor E.A., Vorah C, Wilkinson M. 1990; Analgesic use: a study of treatments used by patients for migraine prior to attending the City of London migraine clinic. Headache 30: 634-638. Manzoni G.C., Micieli G, Granella F, Sandrini G, Zanferrari C, Nappi G. 1988. Therapeutic approach to drug abuse in headache patients. In: Drug-induced headache. Diener H.C., Wilkinson M. eds. 143-149 Springer-Verlag; Berlin: Marks V. 1981. Reactive (rebound) hypoglycemia). In: Hypoglycemia. Marks V, Rose C.F.. eds. 179-217 Blackwell, Oxford; Mathew N.T.. 1987; Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 27: 130-133. Mathew N.T., Kurman R, Perez F. 1990; Drug induced refractory headache clinical features and management. Headache 30: 634-638. Michultka D.M., Blanchard E.B., Appelbaum K.A., Jaccard J, Dentinger M.P.. 1989; The refractory headache patient—2. High medication consumption (analgesic rebound) headache. Behav Res Ther 27: 411-420. Micieli G, Manzoni G.C., Granella F, Martignoni E, Malferrari G, Nappi G. 1988. Clinical and epidemiological observations on drug abuse in headache patients. In: Drug-Induced Headache. Diener H.C., Wilkinson M. eds. 20-28 Springer-Verlag; Berlin: Nicolodi M, DelBianco P.L., Sicuteri F. 1997; The way to serotonergic use and abuse in migraine. Int J Clin Pharmacol Res 17: 79-84. Page H. 1981; Rebound headache from ergotamine withdrawal. JAMA 246: 719. Peters G, Horton B.T.. 1951; Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Mayo Clin 26: 153-161. Pini L.A., Trenti T. 1994. Case report: does chronic use of sumatriptan induce dependence?. Headache. 34 600-601. Pradalier A, Dry S, Baron J.F.. 1984; Cephalée induite par l’abuse de tartrate d’ergotamine chez les migrainieux. Concours Méd 106: 106-110. Rahman A, Segasothy M, Samad S.A., Zulfiqar A, Rani M. 1993; Analgesic use and chronic renal disease in patients with headache. Headache 33: 442-445. Rapoport A, Stang P, Gutterman D.L., Cady R, Markley H, Weeks R, Saiers J, Fox A.W.. 1996; Analgesic rebound headache in clinical practice: data from a physician survey. Headache 36: 14-19. Rapoport A.M.. 1988; a Analgesic rebound headache. Headache 28: 662-665. Rapoport A.M., Weeks R.E.. 1988. b Characteristics and treatment of analgesic rebound headache. In: Drug-induced headache. Diener H.C., Wilkinson M. eds. 162-167 Springer-Verlag; Berlin: Roswell A.R., Neylan C, Wilkinson M. 1973; Ergotamine induced headache in migrainous patients. Headache 13: 65-67. Sandler D.P., Smith J.C., Weinberg C.R., Buckalew V.M., Dennis V.W., Blythe W.B., Burgess W.P.. 1989; Analgesic use and chronic renal disease. N Engl J Med 320: 1238-1243. Saper J.R.. 1983. a Drug abuse among headache patients. In: Headache disorders. Saper J.R.. ed. 263-278 PSG Publishers; Boston: Saper J.R.. 1983; b Drug overuse among patients with headache. Neurol Clin 01: 465-477. Saper J.R.. 1990; Daily chronic headaches. Neurol Clin N Amer 08: 891-902. Saper J.R., Jones J.M.. 1986; Ergotamine tartrate dependency: features and possible mechanisms. Clin Neuropharmacol 09: 244-256. Schnider P, Aull S, Baumgartner C. et al. 1996; Long-term outcome of patients with headache and drug abuse after inpatient withdrawal: five-year followup. Cephalalgia 16: 481-485. Schnider P, Aull S, Feucht M. 1994; Use and abuse of analgesics in tension-type headache. Cephalalgia 14: 162-167. Schnider P, Maly J, Grunberger J, Aull S, Zeiler K, Wessely P. 1995; Improvement of decreased critical flicker frequency in headache patients with drug abuse after successful withdrawal. Headache 35: 269-272. Schoenen J, Lenarduzzi P, Sianard-Gainko J. 1989. Chronic headaches associated with analgesics and/or ergotamine abuse: a clinical survey of 434 consecutive outpatients. In: New advances in headache research. Rose F.D.. ed. 29-43 Smith-Gordon; London: Seller E.M., Busto U.E., Kaplan H.L., Somer G, Baylon G.J.. 1998; Comparative abuse liability of codeine and naratriptan. Clin Pharmacol Ther 63: 121. Shakir R.A.. 1995. Vitamin toxicity. In: Handbook of clinical neurology. vol. 65 DeWolff F.A.. ed. New York: Elsevier Science; 567-576. Silberstein S.D., Lipton R.B.. 1997. Chronic daily headache. In: Headache. Goadsby P.J., Silberstein S.D.. eds. 201-225 Butterworth-Heinemann; Newton: Silberstein S.D., Lipton R.B., Solomon S, Mathew N.T.. 1994; Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 34: 1-7. Silberstein S.D., Silberstein J.R.. 1992; Chronic daily headache: prognosis following inpatient treatment with repetitive IV DHE. Headache 32: 439-445. Stewart J.H.. 1978; Analgesic abuse and renal failure in Australia. Kidney Internat’l 13: 72-78. Sullivan J.T., Sellers E.M.. 1986; Treatment of the barbiturate abstinence syndrome. Med J Aust 145: 456-458. Taschner K.L., Wiesbeck G.A.. 1988. Psychiatric aspects of drug addiction of the barbiturate-alcohol type. In: Druginduced headache. Diener H.C., Wilkinson M. eds. 80-84 Berlin, Springer-Verlag: Tfelt-Hansen P. 1985. Ergotamine headache. In Updating in headache. Pfaffenrath V, Lundberg P, Sjaastad O. eds. 169-172 Springer; Berlin: Tfelt-Hansen P. 1986; The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol 59: 1-29. Tfelt-Hansen P, Krabbe A.A.. 1981; a Ergotamine. Do patients benefit from withdrawal? Cephalalgia 01: 29-32. Tfelt-Hansen P, Olesen J. 1981; b Arterial response to ergotamine tartrate in abusing and non-abusing migraine patients. Acta Physiol Scand 48: 69-72. Tfelt-Hansen P, Paalzow L. 1985; Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther 37: 29-35. Tfelt-Hansen P, Saxena P.R., Ferrari M.D.. 1995. Ergot alkaloids. In: Handbook of clinical neurology. DeWolff F.A.. ed. 61-67 New York: Elsevier Science; Timmings P.L., Richens A. 1995. Neurotoxicology of antiepileptic drugs. In: Handbook of clinical neurology. DeWolff F.A.. ed. 495-513 New York: Elsevier Science; Vasconcellos E, Pina-Garza J.E., Millan E.J., Warner J.S.. 1998; Analgesic rebound headache in children and adolescents. J Child Neurol 13: 443-447. Verhoeff N.P., Visser W.H., Ferrari M.D., Saxena P.R., vonRoyen E.A.. 1993; Dopamine D2 receptor imaging with 123-I-iodobenzamide SPECT in migraine patients abusing ergotamine: does ergotamine cross the blood brain barrier. Cephalalgia 13: 325-329. VonKorff M, Galer B.S., Stang P. 1995; Chronic use of symptomatic headache medications. Pain 62: 179-186. Walker J, Parisi S, Olive D. 1993; Analgesic rebound headache: experience in a community hospital. Southern Med J 86: 1202-1205. Warner J.S.. 1999; Rebound headaches: a review. Headache Quarterly 10: 207-219. Zed P.J., Loewen P.S., Robinson G. 1999; Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother 33: 61-72. Ziegler D.K.. 2000; Opiate and opioid use in patients with refractory headache. Cephalalgia 14: 5-10. 8.3 Kopfschmerz als Nebenwirkung zurückzuführen auf eine Dauermedikation de Lignières B, Silberstein S.D.. Pharmacodynamics of oestrogens and progestagens. Cephalalgia 2000; 20: 200-207. Silberstein S.D.. Hormone-related headache. M Clin N Am 2001; 85: 1017-1035. Silberstein S.D., de Lignières B. Migraine, menopause and hormonal replacement therapy. Cephalalgia 2000; 20: 214-212. 8.4 Kopfschmerz zurückzuführen auf den Entzug einer Substanz Abbott P.J.. 1986; Caffeine: a toxicological overview. Med J Aust 145: 518-521. Baumgartner G.R., Rowen R.C.. 1991; Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 84: 312-321. Dalessio D.J.. 1980. Wolff’s headache and other head pain. Oxford University Press, Oxford: Epstein M.T., Hockaday J.M., Hockaday T.D.R. 1975; Migraine and reproductive hormones through the menstrual cycle. Lancet i: 543-548. Greden J.F., Fontaine M, Lubetsky M, Chamberlin K. 1978; Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatr 135: 963-966. Laska E.M., Sunshine A, Mueller F, Elvers W.B., Siegel C, Rubin A. 1984; Caffeine as an analgesic adjuvant. JAMA 251: 1711-1718. Lichten E, Lichten J, Whitty A, Pieper D. 1996; The confirmation of a biochemical marker for women’s hormonal migraine : the depo-oestradiol challenge test. Headache 36: 367-71. Raskin N.H., Appenzeller O. 1980. Headache, Saunders; Philadelphia: Silverman K, Evans S.M., Strain E.C., Griffiths R.R.. 1992; Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Eng J Med 327: 1109-1114. Somerville B. 1975; Estrogen withdrawal migraine. Neurology 25: 239-250. vanDusseldorp M, Katan M.B.. 1990; Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. Br Med J 300: 1558-1559. White B.C., Lincoln C.A., Pearcz N.W., Reeb R, Vaida C. 1980; Anxiety and muscle tension as consequence of caffeine withdrawal. Science 209: 1547-1548.
